What 503A Compounding Pharmacies Currently Cannot Make These widely used clinical peptides are not eligible for 503A compounding under current rules: BPC-157 (Body Protective Compound, used for tendon, ligament, and gut-lining repair) TB-500 / Thymosin Beta-4 fragment (recovery and inflammation modulation) CJC-1295 (GHRH analog, used for growth hormone optimization) Ipamorelin (selective GH secretagogue) MOTS-c (mitochondrial-derived peptide, metabolic and longevity research) Epithalon (Epitalon) (telomere-supporting longevity peptide) Semax (cognitive and neuroprotective peptide) GHK-Cu (copper tripeptide for skin and tissue regeneration) AOD-9604 (modified fragment of growth hormone, studied for fat metabolism) These peptides are widely studied
At the same time, a vitamin B12 deficiency is only one possible contributor toward an iron deficiency
Consider Vitamin B12 Injections If the Vitamin B12 deficiency or its malabsorption is severe, the doctor may prescribe Vitamin B12 shots
Get 20% off your first peptide order Join for early access when the service launches mL mg/mL Reconstituting your vial Reconstitution is adding liquid, almost always bacteriostatic water, to a freeze-dried (lyophilized) peptide so you can measure and inject it
Presented for research literature review only Barker GA et al